We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Supersensitive MEG Operates at Room Temperature

By MedImaging International staff writers
Posted on 26 Aug 2021
Print article
Image: A new MEG sensor works at room temperature (Photo courtesy of Maxim Ostras/ RQC)
Image: A new MEG sensor works at room temperature (Photo courtesy of Maxim Ostras/ RQC)
A novel solid-state magnetoencephalography (MEG) sensor that works at room temperature could reduce brain mapping costs by an order of magnitude.

Developed at the Russian Quantum Center (RQC; Moscow, Russia), the Skolkovo Institute of Science and Technology (Skoltech; Moscow, Russia), and other institutions, the new fluxgate MEG sensor is a based on yttrium-iron garnet films (YIGM) that are capable of registering very weak or deep electrical sources in the brain. Owing to its wide dynamic range, the device requires less magnetic shielding, which means a lower cost of both the hardware and the entire research infrastructure.

In a feasibility study, the researchers proved the concept of usage of the YIGM in terms of MEG by registering a simple brain induced field, the human alpha rhythm, which constitutes of sinusoidal electric currents in the back of the brain. The new sensor successfully detected the onset of alpha rhythm, and the result was validated by a highly sensitive optically pumped magnetometer, which currently appears to be well-established in terms of MEG. The study was published on July 30, 2021, in Human Brain Mapping.

“Although our quantum device and the classical flux-gate sensor have similar operating principles, in our case, the quantum exchange interaction helped detect a magnetic field with a magnitude 1,000 times lower compared to conventional solutions,” said study co-author Maxim Ostras, PhD, head of the project at RQC. “Moreover, its high sensitivity coupled with all the advantages of classical flux-gate sensors makes our device a truly universal magnetometer ideally suited for brain research.”

“Even the first prototype of the sensor in some cases showed higher sensitivity in MEG as compared to existing systems, which, combined with its simplicity and solid-state nature, suggests that systems based on this technology have a bright future ahead of them,” said Professor Nikolay Koshev, PhD, of Skoltech. “There is still a lot of work to be done, including further research into the physical properties of the sensor and the development of a new mathematical apparatus that will ensure high-efficiency signal processing for this new specific type of magnetometer.”

MEG is a neuroimaging modality that combines non-invasiveness with high spatial and temporal resolution, which makes it suitable for studying complex functional brain integration processes. The first MEG study in humans was in 1972, when a superconducting quantum interference device (SQUID) was used to register alpha activity. But SQUID-based MEG devices require a cumbersome fixed-size helmet dewar and have high maintenance costs, due to the constant need for sensor cooling with liquid helium.

Related Links:
Russian Quantum Center
Skolkovo Institute of Science and Technology


Ultra-Flat DR Detector
meX+1717SCC
Ultrasound Imaging System
P12 Elite
X-Ray Illuminator
X-Ray Viewbox Illuminators
3T MRI Scanner
MAGNETOM Cima.X

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.